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ABSTRACT 
 
PURPOSE: To determine whether a compensatory increase in food intake occurs following a 
day of fasting, and to determine whether leptin and/or ghrelin levels change in response to ADF 
compared with ad libitum feeding.  
INTRODUCTION: Recently, alternate-day fasting (ADF) has grown in popularity as an 
alternative to continuous energy restriction (CER) diets as a method for improving health and 
controlling food intake. Leptin and ghrelin are two hormones implicated in the regulation of food 
intake and body weight, however their response to ADF is unclear. 
METHODS: Male Wistar rats of the same age and weight were randomly assigned to the ADF 
group (n=7) or a control group (n=7). The ADF group had alternating 24-hour fasting and 
feeding days for 30 days. Fasting rats were limited to 3-5g of regular chow on fasting days and 
were given food ad libitum on feeding days. The control group had food ad libitum everyday for 
the same 30 days. Food intake for each animal was measured on a digital scale and recorded 
daily, and body weight was measured weekly. 600 μl blood was taken from the tail of each rat at 
the end of day 1, day 2, day 29, and day 30, to measure hormone levels after a fasting and 
feeding day before and after the ADF intervention trial. Leptin and ghrelin levels were 
determined by radioimmunoassay.  
RESULTS: Food intake by ADF rats was increased by 20% on ad libitum feeding days (F = 
3.484, p = .047), however ADF rats had lower rates of weight gain compared to the control 
group (290 g vs 355 g; F = 41.604, p < .001). Total percent body fat was significantly higher in 
the ADF group compared with the control group (19.9% vs 15.6%; t = -2.848, p = .015). Diet 
had no significant effect on leptin levels (F = .134, p = .895). Ghrelin concentration was 
significantly lower on the last feeding day and significantly higher on the subsequent fasting day 
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in the ADF animals at the end of the study compared with starting values (854.8 à 1475.3 pg/ml 
(post) vs 1085.9 à 1306.6 pg/ml (pre); t = -3.97; p = .007). 
CONCLUSION: Results of this study indicate that food intake on feeding days did not 
sufficiently increase to offset the calorie deficit incurred on fasting days. Despite a decrease in 
weight gain, percent body fat increased in the ADF group. This appears to be the result of an 
adaptive change in ghrelin sensitivity in response to the alternate day fasting regimen. 
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CHAPTER 1 
INTRODUCTION 
Weight loss continues to be a growing concern for many people in industrialized 
countries. Key components in weight loss are increases in daily physical activity level and diet 
modifications including appetite control. Though consumers have become more concerned with 
“healthy” and “fresh” foods, most highly available and affordable foods tend to be those that are 
high in calories. Easy access to high calorie foods, combined with multi-media advertisements 
make appetite control one of the harder obstacles to overcome when trying to lose weight. 
Though appetite and hunger are sometimes used interchangeably, there are distinct differences 
between the two. Hunger is defined as the physiological need for food due to depletion of 
nutrients and is associated with discomfort or weakness caused by lack of food. Appetite is the 
desire to eat food, which can be separate from hunger, and is influenced by the external factors 
such as the smell of food being cooked, food advertisements, social settings, etc. Controlling 
food intake, regardless if it is induced by hunger or appetite, is the key to successfully sustaining 
weight loss.  
Recently, intermittent fasting (IF) has grown in popularity as an alternative to continuous 
energy restriction (CER) diets as a method for improving health and controlling food intake. 
CER requires individuals to cut caloric intake by 20-40% every day while maintaining daily 
meal frequency [1]. Many deviations of IF exist, however alternate-day fasting (ADF) has 
become a popular variation in the past decade. In ADF, food is completely removed or extremely 
reduced (less than 500 kcals/day) for 24 hours on one day, followed by a non-fasting day where 
food is consumed ad libitum. The ability to eat freely on feeding days without having to count 
calories becomes a very attractive idea for most people. The main assumption of this diet is that 
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most people cannot consume twice their daily caloric need on the feeding days, thus lowering 
caloric intake over time. Though fasting for 24 hours seems difficult, advocates of the diet say 
that their desire to eat lessens on fasting days, and studies have shown high compliance during 
short-term ADF trials [2]. Both ADF and CER have been shown to promote weight loss, extend 
lifespan, and protect against insulin disorders, cardiovascular disease, and neurological disorders 
in mice [3]. However, studies on the effects of ADF on hormones related to food intake have 
shown mixed results [2, 4-16]. A few studies[2, 4-6, 11-14, 17, 18] have examined the effects of 
ADF on leptin and ghrelin in relation to chronic diseases such as diabetes and cardiovascular 
disease, but no studies have examined the possible interactions of these hormones and their 
relation to food intake. 
While food intake can be affected by a number of factors, certain circulating hormones 
can influence a person’s energy expenditure and desire to eat. Hormones secreted from the 
stomach (cholecystokinin, ghrelin, peptide YY), the pancreas (glucagon, insulin), and adipose 
tissue (adiponectin, IL-6, leptin, resistin) all play a role in appetite regulation and nutrient 
metabolism [19]. The “hunger hormone” ghrelin has been shown to promote fat deposition, and 
stimulate AMP kinase and neuropeptide Y (NPY) expression, thus eliciting food intake. 
Conversely, the “satiety hormone” leptin has been shown to increase fat metabolism and inhibit 
AMP kinase and NPY expression, which suppresses feeding [20, 21]. This study will focus on 
leptin and ghrelin because of the strong influence these hormones have on regulating food intake 
and body weight [22]. 
The purpose of this study is to determine whether a compensatory increase in food intake 
occurs following a day of fasting. A second purpose is to determine whether leptin and/or ghrelin 
levels change in response to ADF compared with ad libitum feeding.  
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Though several ADF studies have been done with human subjects, this study will focus 
on the hormonal response in rats. Using a rodent model for this experiment will allow for control 
of physical activity, calorie intake and nutrient intake so that just the effects of the fasting and 
refeeding trial can be observed. 
Research Question 1: Do rats increase food intake on fed days to offset energy deficits incurred 
on fasted days? 
H0: Rats will increase food intake on fed days to offset energy deficits on fasted days. 
H1: Rats will not increase food intake on fed days to offset energy deficits on fasted days. 
Research Question 2: Do leptin levels change in response to ADF compared with ad libitum 
feeding? 
H0: There will be no significant difference in plasma leptin levels between the ad libitum fed 
group and ADF group. 
H1:  There will be significantly different plasma leptin levels in the ADF group compared 
with the ad libitum fed group. 
Research Question 3: Do ghrelin levels change in response to ADF compared with ad libitum 
feeding? 
H0: There will be no significant difference in plasma ghrelin levels between the ad libitum 
fed group and ADF group. 
H1:  There will be significantly different plasma ghrelin levels in the ADF group compared 
with the ad libitum fed group.  
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CHAPTER 2 
LITERATURE REVIEW 
Fasting and Alternate-day fasting 
Fasting has been a common practice for many through integration in religious practices 
(ex. Ramadan, Lent, Yom Kippur). By definition, fasting is considered low or no calorie intake 
for a time period of 12 hours to a few weeks. Some physicians prescribe very low calorie fasting 
periods lasting over a week, but patients need to be closely monitored in specialized clinics [1]. 
Few “periodic fasting” diets require subjects to fast for two or more consecutive days with the 
fasts at least 1 week apart to keep weight from decreasing too dramatically. However, it is 
thought that intermittent fasts (IF) can induce similar benefits to those found in the longer 
periodic fasting diets due to the high frequency of the fasting cycles [1, 23].  
Many variations of IF exist which are sometimes coupled with very constrained eating 
habits. Some variations involve fasting for part of the day, about 12-20 hours, followed by a 
highly regimented food intake for the remaining hours (ex. Leangains, The Warrior Diet). Other 
IF options have longer, less frequent fasting periods (only 1-2 times per week), which then are 
followed by an unrestricted eating for the rest of the week (Eat Stop Eat diet).  The effect of 
differing variations of IF on lifespan in rats was tested [24]. Wistar rats (N=137) aged 42 days 
were distributed between 4 groups based on littermates and gender: control, fasting 1 in 4 days, 
fasting 1 in 3 days, and fasting 1 in 2 days. Rats were continued on their assigned diet until 
death. Results showed that the extension of life by fasting was almost proportional to the amount 
of fasting, however more complications were found in 1 in 4 days and 1 in 2 days IF groups. The 
lifespan of male rats improved more than females (90 days and 23 days, respectively), but female 
rats lived longer on average. Interestingly, the weights of IF rats were lower than the control 
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group with no significant retardation of growth in the rats. This was one of the first studies to 
compare different IF diets in relation to prolonged lifespans. The authors also noted that the IF 
treatments may help delayed the development of mammary tumors and other types of tumors 
compared to littermates in the control group, which could lead to longer lifespans as well. The 
ADF diet, also known as “alternate day calorie restriction” or  “every other day diet,” has been 
gaining significant scientific interest due to its comparable health benefits as continuous energy 
restriction (CER), but with higher dietary adherence in patients [2, 25, 26].  Though ADF was 
not tested in this experiment, its benefits on aging have been reviewed in both rodents and 
humans.  
 The exact causes of aging are currently unknown, however the prevailing theory is that 
oxidative stress causes damage within the cells leading to dysfunction and deterioration of cell 
[27]. When energy is produced during normal aerobic metabolism, reactive oxygen species 
(ROS) are formed as a byproduct. ROS are unstable oxygen radicals that have a higher reactivity 
than regular oxygen molecules. Though ROS play a role as signaling molecules for specific 
reactions, elevated levels can cause damage to lipids, proteins, and DNA. During aging, 
antioxidant and repair mechanisms that are needed to remove the ROS gradually become 
impaired. In mice, ADF has shown to help prevent age-related damage to antioxidant enzymes in 
bodily tissues. Coenzyme Q is an essential enzyme found in cell membranes and plays an 
important role in cellular metabolism and antioxidant activities [28]. Coenzyme Q may modulate 
a signaling pathway in the plasma membrane by reducing lipid peroxidation and certain 
coenzyme Q-dependent pathways can be effect by diet and exercise. The differing effects of age 
and diet were observes in male Swiss-OF1 mice aged 1-month and 11-month. Mice were then 
randomly assigned to four experimental groups: ad libitum sedentary (AL), ad libitum active 
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(ALT), ADF sedentary (EOD), and ADF active (EODT). After 6 months, no significant 
differences in coenzyme Q concentrations were found between the young and old groups. 
However, older mice in the EOD and EODT groups had significantly higher total coenzyme Q 
concentrations than the old AL group and young mice in the same group. The EOD and EODT 
groups also showed significant decreases in lipid peroxidation. Decreased rates of lipid 
peroxidation were also found in a similar experiment, which focused on the effects of ADF on 
antioxidant activity in 3.5-month-old female Wistar rats [29]. Combined these studies show a 
potential role for ADF in antioxidant protection. 
Furthermore, ADF in rodent models has been shown to protect neurons against oxidative 
stress in neurodegenerative disorders, such as Alzheimer’s and Parkinson’s disease [30]. Positive 
effects of ADF are not just protective; ADF can also affect chronic issues. Johnson et al. studied 
the effects of ADF in obese asthmatic patients on symptoms, pulmonary function, oxidative 
stress, and inflammation [26]. Significant improvements in asthma-related symptoms and 
pulmonary functions were seen with the first 2 weeks and continued to improve until the end of 
the study. Participants had significant decreases in inflammatory and oxidative stress markers, as 
well as serum cholesterol and triglycerides.  
 The possible benefits of intermittent fasting/energy restriction and ADF on 
cardiovascular health and glucose metabolism have been extensively reviewed [12, 25] . To date, 
both human and rodent studies have shown IF and ADF can promote weight loss and improve 
health factors such as: insulin/insulin resistance, fasting blood glucose, and blood lipids profiles. 
In mice, modified ADF has been shown to modify body fat distribution, triglyceride metabolism, 
and adipokine secretion in a way that could be cardioprotective regardless of fat intake [13]. 
Male mice (N=18) were randomly assigned to one of three groups for four weeks: alternate day 
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fasting with low fat diet (ADF-LF), alternate day fasting with high fat diet (ADF-HF), and 
control group. Unlike many ADF studies in rodents, food restriction on fasting days was only cut 
by 85% (instead of 100%) and then fed ad libitum on feeding days. Though there were no 
significant differences in body weight between all three groups, both ADF groups had 
significantly greater amounts of subcutaneous fat and significantly lower percentages of visceral 
fat compared to control groups. Interestingly, mean energy intake between ADF-LF and ADF-
HF was similar, despite differences in macronutrient composition. The adipokines leptin and 
resistin showed significant reductions in plasma concentrations of both ADF groups when 
compared to control group, though the ADF-LF group had greater reductions than the ADF-HF 
group. The combination of decreased visceral fat and the pro-inflammatory facilitator resistin 
promote ADF as method to protect against cardiovascular disease and atherosclerosis, even in 
the presence of a high fat intake in rodents. Similar improvements in adipose tissue physiology 
after a period of modified ADF has been seen in a human trial looking at the same parameters 
[18].  
Harvie et al. compared the responses in whole body glucose metabolism and lipid profile 
after six months of ADF or CER in overweight women [8]. Subjects had comparable decreases 
in total cholesterol, LDL cholesterol, and triglycerides, but the ADF group had a greater decrease 
in fasting insulin levels, meaning this group had greater improvements in glucose metabolism 
than CER group. Prior to this, a similar study was done in eight non-obese males on an IF 
regimen of fasting for 20 hours every two days [31]. After 14 days, subjects maintained a 
constant weight and saw an increase in insulin-mediated glucose uptake and inhibition of adipose 
tissue lipolysis. However, no significant changes in fasting insulin levels were detected, which 
could be due to the short study length. 
 8 
 Negative effects of ADF have only been shown in two rodent studies. After eight months 
of ADF obesity-prone rats had an increase in reactive oxygen species (ROS), which increases 
inflammation and could lead to chronic disease development [32]. The other adverse reaction to 
ADF was seen in rats on a six month ADF trial, in showed significant decreases in diastolic 
compliance and increased myocardial fibrosis were found [4].  
As seen above, the effects of ADF on health is still unclear. Some studies have 
demonstrated positive effects [12, 25, 26, 28-30], while others have shown no effect on health 
markers [4, 8, 9, 31, 32]. Understanding the mechanisms responsible for these effects are 
necessary for determining the efficacy and safety of this diet. In a review, Varady and Hellerstein 
note that weight seems to be the main confounding variable in ADF studies in both rodent and 
human models [12]. It is known that weight loss in obese populations can improve health and 
decrease risk for disease, however not all ADF studies showed decreases in weight. Studying the 
influence of ADF on appetite and appetite-related hormones could provide an answer to those 
conflicting results. 
 
AMP Kinase Regulates Food Intake 
AMP kinase is an enzyme that is expressed in many tissues, including brain, liver, 
cardiac and skeletal muscles. AMP kinase activation in the body can be affected by physiological 
and pathological stresses that increase ATP consumption or inhibit ATP production [19, 33]. 
AMP kinase acts as a sensor of cellular energy status by measuring the adenosine 
monophosphate (AMP) to adenosine triphosphate (ATP) ratio. On the cellular level, ATP is 
converted to ADP (adenosine diphosphate) when energy is needed. Two ADP molecules are then 
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transformed into one ATP and one AMP molecule. As more energy is consumed, the ratio of 
AMP to ATP increases and activates AMP kinase.  
When AMP kinase is activated in the periphery, anabolic cellular processes are down-
regulated and catabolic cellular processes are up-regulated to generate more ATP [19]. Unlike 
peripheral tissues, AMP kinase activity in the brain (specifically the hypothalamus) causes more 
complex reactions. Activation of the AMP kinase in certain areas of the hypothalamus increases 
food intake and body weight, while suppression of AMP kinase reduces these factors [34]. Male 
FVB mice (aged 7-9 weeks) were used to observe changes in food intake and body weight 
through alterations in hypothalamic AMP kinase activity. Mice were implanted with a brain 
cannula and injected with recombinant adenovirus to express constitutively active AMP kinase 
(CA-AMPK) or dominant negative AMP kinase (DN-AMPK) in the medial hypothalamus. All 
mice lost weight two days post injection, but mice expressing DN-AMPK lost significantly more 
weight than CA-AMPK and control mice and regained weight more slowly. Also, overall food 
intake in CA-AMPK mice was significantly higher than DN-AMPK and control mice after eight 
days. This study showed that changes in hypothalamic AMPK activity could affect food intake 
and body weight. The authors concluded this is effect is partially due to alterations in the 
expression of orexigenic neuropeptides, neuropeptide Y (NPY), and agouti-related peptide 
(AgRP). In the same study, the authors discovered that high AMP kinase activity, like those 
found in CA-AMPK mice, stimulates feeding signals during fasted states. Conversely, low AMP 
kinase activity, like those found in DN-AMPK mice, suppressed feeding signals during 
unrestricted feeding. These results provide an insight into how various changes in hypothalamic 
AMP kinase can influences appetite and food intake. 
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AMP kinase regulates energy intake and body weight by mediating the opposing effects 
of anxoregenic (appetite-suppressing) and orexigenic (appetite-stimulating) signals in the 
hypothalamus. These hypothalamic signals include nutrient/substrate levels (ex. glucose and 
fatty acids), certain peptides, and circulating hormones [19]. Alterations in AMP kinase activity 
can have major effects on energy homeostasis in the body and can be seen in those suffering 
from obesity [22]. A study on male FVB mice was performed to determine whether diet-induced 
obesity (DIO) impaired AMP kinase response to leptin in the hypothalamus or in muscles [35]. 
Mice were randomly assigned to the control group (chow diet) or the DIO group (high-fat diet). 
After 10 weeks on the diets, six mice from each group were injected intraperitoneally with leptin 
or saline. Food intake after 24 hours of leptin injection in chow fed mice decreased more than 
30%, but did not decrease significantly in DIO mice. Leptin-resistance can be found in many 
cases of obesity, thus alterations in leptin-AMP kinase signaling may play a significant role in 
appetite control.  
 
Role of Leptin and Ghrelin 
AMP kinase activity can be affected by hormonal changes due to fasting and refeeding. 
Refeeding increases blood glucose and insulin, which triggers a rise in leptin synthesis and 
secretion. Leptin is classified as an adipokine, a group of peptides and hormones secreted by 
white adipose tissue, though it is also secreted by the gastric mucosa. The role of gastric leptin is 
short-lived and is directed more towards food absorption in the intestines, whereas adipocyte 
leptin is involved feeding signals and energy storage [36]. In the hypothalamus, circulating leptin 
decreases AMP kinase activity by inhibiting the expression of NYP and AgRP. Under normal 
conditions, leptin triggers a feedback mechanism to the brain to decrease food intake and 
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increase energy expenditure [22]. High levels of leptin are seen in obese individuals across all 
ages due to high percentages in body fat leading to leptin insensitivity. However, calorie 
restriction has been shown to increase responsiveness to leptin in older rats more so than younger 
rats [37]. Conversely, very low leptin concentrations have been seen in patients with exercise-
induced amenorrhea and anorexia nervosa [38]. Amenorrheic female athletes had significantly 
lower leptin levels and abnormal diurnal leptin patterns than the weight-match and body-fat 
matched controls and eumenorrheic athletes. Thus, body fat cannot fully explain the decrease in 
circulating leptin concentrations. In agreement with this, Weigle et al. discovered a decrease in 
leptin concentration that was disproportional to body fat loss after a three day (72 hour) fast in 
male subjects [39].   
On the other hand, fasting induces a decrease in blood glucose levels and elicits the 
secretion of ghrelin, an orexigenic hormone, in the stomach. Ghrelin increases AMP kinase 
activity mainly in the hypothalamus and in specific tissues – the heart, liver, and adipose tissue. 
Ghrelin increases the expression of NPY and AgRP, which elicits food intake and fat deposition. 
In rats, it was indicated that leptin was an upstream regulator of ghrelin secretion, however that 
cannot be confirmed in human subjects [22]. Unlike leptin, ghrelin is not necessary for 
maintenance of energy homeostasis. In ghrelin knockout mice, body composition and size, bone 
density, and food intake were similar to normal control mice [40]. Obese individuals may have 
an impaired suppression of ghrelin in response to feeding, but plasma concentrations are 
typically lower than lean individuals [9]. In rats, extreme obesity followed chronic administration 
of ghrelin in the absence of leptin. Thus, the effects of chronic ghrelin infusion were observed in 
humans. Continuous infusion of ghrelin increased appetite and food intake in humans in a short-
term study [41]. Nine subjects were continually administered ghrelin for 270 minutes. After the 
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infusion, the subjects were treated to a buffet-style lunch and food intake was recorded. All 
subjects had an increased food intake and there was no compensatory under-eating the rest of the 
day.  
Some studies have compared the relation of leptin and ghrelin during fasting state. The 
effects on leptin and ghrelin during normal diurnal conditions, restricted feeding, and sleep 
deprivation were studied on male Sprague-Dawley rats [20]. The diurnal rhythms of leptin and 
ghrelin were at opposite times of the day, with peak levels of leptin occurring during active times 
and peak ghrelin levels occurring during sleep. In the second experiment, 8 rats were put on a 
12-hour food restriction diet (RF) for 3 weeks. This was achieved by removal of feeders at dark 
onset (active time) and returned at light onset (sleep). In a previous study, rats were shown to 
adapt to this dietary regimen after 1 week. Correspondingly, food intake and body weight were 
not significantly different between the free feeding rats and the RF rats. High rates of food intake 
were observed in the first hour of the light period, thus greatly impacting plasma leptin and 
ghrelin levels. Peak and 24-hour ghrelin levels were significantly higher in the RF rats than the 
free-feeding group. 24-hour leptin concentrations were significantly higher in the RF rats than 
control and peak leptin values were also slightly higher, but not significant.  
 Despite the implications of ghrelin as the “hunger hormone,” few studies have seen any 
changes in ghrelin concentrations after a period of intermittent fasting. Heilbronn et al. showed 
decreases in weight and fasting insulin levels in non-obese men and women, but no changes were 
found in fasting ghrelin levels after 22 days of ADF [9]. Accordingly, no significant changes in 
plasma ghrelin concentrations were found in 8 males after Ramadan fasting and no association 
was found between plasma leptin and ghrelin levels [42]. However, leptin levels showed 
significant reductions during Ramadan for these subjects, which have also been seen in other 
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studies measuring at leptin concentrations. A few studies showed significant decreases in plasma 
leptin levels after a period of IF lasting from two weeks to six months [8, 11, 31]. However, one 
study done in female rats showed no changes in plasma leptin levels after one month of ADF 
[10].  With such mixed results in humans, observation of ADF on leptin and ghrelin 
concentrations should be made in order to determine if these factors have a mechanistic role in 
the positive outcomes of this dietary regimen. 
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CHAPTER 3 
METHODOLOGY 
Animals: Fourteen male Wistar rats of similar age and weight (approximately 10 weeks 
old; 175.07 g ± 6.44) were obtained from Charles River (Wilmington, MA). Rats were randomly 
assigned to either the ADF group (n=7) or the control group (n=7), and housed individually in a 
12-hour light/dark cycle at UNLV’s Laboratory Animal Care Facility. Body weight for each rat 
was recorded prior to the initiation of treatment, once a week during treatment, and prior to 
euthanization at the completion of the 30-day treatment. 
Diet: Standard rodent chow (PicoLab Rodent Diet 20; Lab Diet, St Louis, MO) was given 
to both groups every morning. The ADF group had alternating 24-hour fasting and feeding days 
for 30 days.  Fasting rats were limited to 25% of estimated daily caloric need on fasting days. 
About 3 g of regular chow was given initially and then was gradually raised to 6 g as weight 
increased. This was followed by an ad libitum feeding day, where rats were provided 50-60 g of 
food. The control group was provided 50-60 g of food everyday for ad libitum feeding for the 
same 30 days. Both groups had continuous access to water. Food intake for both groups was 
measured on a digital scale and recorded daily.  
Radioimmunoassays (RIA): Blood was obtained via tail clip (0.5 mm tip of tail) from 
each rat at the end of day 1 (fed), day 2 (fast), day 29 (fed), and day 30 (fast), allowing for 
changes in hormone levels after a fasting and feeding day to be compared before and after the 
ADF intervention. All samples were collected between 9:00-10:00am each day. 600µl of blood 
was collected in capillary tubes (Microvette 600, Sarstedt, Nümbrecht, Germany), centrifuged, 
plasma removed, and stored at -70° C until assayed. Following the tail clip on days 1 and 2, 
animals were returned to cages and started on ADF or CON dietary regimen for 30 days. Plasma 
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samples were analyzed for leptin and ghrelin levels using multi-species leptin RIA kit (EMD 
Millipore Corporation, Billerica, MA, USA) and rat ghrelin RIA kit (Phoenix Pharmaceuticals, 
Inc., Burlingame, CA, USA), according to manufacturers’ instructions.   
Blood Glucose: Prior to blood collection in capillary tubes on day 2 and 30, blood 
glucose levels were determined via blood glucose monitor (Ascensia Contour, Bayer Healthcare 
LLC, Mishawaka, IN).  
Body Composition & Bone Mineral Density: After blood collection on day 30, animals 
were euthanized via CO2 inhalation; body composition (percent body fat) and bone mineral 
density was determined by dual energy x-ray absorptiometry (DEXA) (GE Lunar, Madison, WI) 
using the small animal software. Animal carcasses were placed on an absorbent underpad to 
separate the carcass from direct contact with the DEXA surface.  Following DEXA scans, 
epididymal fat pad were removed and weighed, and carcasses were returned to LACF for 
disposal.   
 Statistics: Analyses were performed using Statistical Package for the Social Sciences 
(SPSS, version 23) software. Differences in food intake, body weight, serum leptin, and serum 
ghrelin before and after treatment were analyzed by mixed model ANOVA. Independent t-test 
was used to compare mean values of body fat between the ADF and control group. Statistical 
significance was set to α=0.05.	 
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CHAPTER 4 
RESULTS 
Weight in the control group doubled over the 30-day treatment period (176.6 g; 355.1 g), 
whereas there was only a 67% increase in the ADF group (173.6 g; 290.3 g) (Table 1). There 
was a significant interaction between diet regimen and body weight (F = 41.604, p < .001) 
(Figure 1). Simple main effects analysis was conducted to determine the nature of the interaction. 
Independent t-tests showed that there was no significant difference in weight between groups 
prior to treatment (p = .405); however, weight in the ADF group was significantly lower in 
weeks 1, 2, 3, and 4 (t = 11.046, t = 5.645, t = 9.778, t = 5.731, respectively; p < .001). One way 
repeated measures ANOVA showed significant weight gains in both group at each of the time 
points (p < .05), except there was no significant weight gain between Week 2 and Week 3 in the 
ADF group (p = .213).  
Daily food intake averaged over 10 days in the ADF was 32% lower than in the control 
group (Table 2). However, there was no significant interaction found in average daily food intake 
between the control and the ADF group (F = 2.127, p = .141) (Figure 2), indicating that food 
intake increased in both over the 30-day study period as the animals grew. Interestingly, food 
intake on feeding days in the ADF group was 25% higher than in the control group (Figure 3 and 
4). A significant interaction was found between diet regimen and 10-day average intake for fed 
days only (F = 3.484, p = .047). Independent t-tests showed the ADF group had significantly 
higher fed-day intake at each of the 10-day time points (t = -4.745, t = -5.682, t = -6.019, 
respectively; p < .001). One-way repeated measures ANOVA showed significant increases in 
feeding days for both groups at each of the time points (p < .05). This shows that food intake did 
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increase significantly on feeding days in the ADF group, but the increase was not enough to 
compensate for the restricted intake on the fasting days. 
Blood glucose was significantly lower in the ADF on the last fasting day (Day 30, Post) 
versus the first fasting day (Day 2, Pre) (t = 6.087, p < .001). Post ADF blood glucose was also 
significantly lower than post control blood glucose (t = 5.162, p < .001) (Figure 3). 
Percent body fat and fat pad weight are shown in Table 3. Despite having lower weight 
gains, the ADF group had significantly higher total percent body fat (t = -2.848, p = .015) and 
significantly higher trunk region fat (t = -2.328, p = .038) than the control group (Figure 4). 
However, the fat pad weight in the control group was significantly higher than the ADF group (t 
= 4.290, p = .001), suggesting a change in fat distribution with ADF. In addition, bone mineral 
density (BMD) was also significantly decreased in the ADF group (t = 3.000, p = .011). 
Plasma leptin and ghrelin concentrations are shown in Table 4. Leptin showed no 
significant interaction with diet regimen (F = .134, p = .895) (Figure 5). However, there was a 
change in overall leptin concentration between Day 1 and Day 2 (p = .007), and between Day 29 
and Day 30 (p < .001); this suggests a variation in leptin secretion that is unrelated to diet. 
Similarly, there was no significant interaction between diet regimen and ghrelin concentrations 
(F = 1.256, p = .304) (Figure 6). However, pairwise comparison for ghrelin showed significance 
between Day 29 and Day 30 (p = .005).  
Table 1: Body Weight 
 Pre Week 1 Week 2 Week 3 Week 4 
Control (g) 176.6 ± 4.89 231.3 ± 7.43 278 ±15.49 324 ± 18.24 355.1 ± 23.33 
ADF (g) 173.6 ± 7.79 185.7 ± 7.99* 236.4 ± 11.82* 241 ± 13.10* 290.3 ± 18.77* 
Values are mean ± standard deviation; * Significantly different than control (p < 0.05) 
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Figure 1: Body Weight  
 
Values are means ± standard error. * Significantly lower than control (p < 0.05) 
 
Table 2: 10-Day Average Daily Food Intake 
 Day 1-10 Day 10-20 Day 20-30 
Control (g) 20.04 ± 1.43 23.10 ± 1.87 24.00 ± 2.03 
ADF (g) 13.18 ± 0.92 14.33 ± 0.91 18.32 ± 1.04 
Fed Days ADF (g) 24.55 ± 2.07* 28.69 ± 1.81* 30.57 ± 2.05* 
Values are mean ± standard deviation; * Significantly higher than control (p < 0.001) 
 
Figure 2: Average Daily Food Intake 
 
Values are means ± standard error. 
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Figure 3: Average Fed Day Food Intake 
 
Values are mean ± standard error; * Significantly higher than control (p < 0.001) 
 
Figure 4: Fed Day Food Intake Timeline 
  
 
Table 3: Pre & Post-Diet Blood Glucose 
 Pre (Day 2) Post (Day 30) 
Control 89 ± 7 87 ± 9 
ADF 87 ± 5 60 ± 11*✪ 
Values are means ± standard deviation; * Significantly different from Pre value (p < 0.001); ✪ Significantly different 
from control (p < 0.001) 
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Figure 5: Pre & Post-Diet Blood Glucose 
 
Values are means ± standard error. Measured following the first fasting day (Pre) and the last fasting day (Post); * 
Significantly different from Pre value (p < 0.001); ✪ Significantly different from control (p < 0.001) 
 
Table 4: Body Composition Results 
 Body Fat % Trunk Fat % Fat Pad (g) 
Control 15.6 ± 2.09 14.3 ± 2.51 3.57 ± 0.41* 
ADF 19.9 ± 3.41* 18.0 ± 3.45* 2.76 ± 0.29 
Values are mean ± standard deviation; * Significantly higher value (p < 0.05) 
 
Figure 6: Body Fat Percentage 
 
Values are mean ± standard error; * Significantly different from control (p < 0.05) 
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Table 5: Bone Mineral Density 
 BMD (g/cm
2) 
Control 0.151 ± 0.014 
ADF 0.134 ± 0.005* 
Values are mean ± standard deviation; * Significantly lower value (p = .01) 
 
 
Figure 7: Bone Mineral Density 
 
Values are mean ± standard error; * Significantly lower from control (p = .01) 
 
Table 6: Group Means for Plasma Leptin and Ghrelin 
    Day 1 (Fed) Day 2 (Fast) Day 29 (Fed) Day 30 (Fast) 
Leptin 
(ng/ml): 
Control (n=7) 15.95 ± 10.0 7.53 ± 1.47 20.42 ± 5.25 8.15 ± 1.09 
ADF (n=7) 17.36 ± 6.73 6.78 ± 1.05 21.85 ± 6.43 8.63 ± 2.25 
Total (n=14) 16.66 ± 8.24 7.15 ± 1.29* 21.14 ± 5.69 8.39 ± 1.72✪ 
Ghrelin 
(pg/ml): 
Control (n=7) 1170.7 ± 576.1 1193.0 ± 419.0 922.7 ± 249.6 1196.1 ± 248.4 
ADF (n=7) 1085.9 ± 229.6 1306.5 ± 361.5 854.8 ± 251.9 1475.3 ± 304.5 
Total (n=14) 1128.3 ± 423.6 1249.8 ± 380.5 888.8 ± 243.5 1335.7 ± 303.7✪ 
Values are mean ± standard deviation; * Significantly different from Day 1 (p = 0.007); ✪ Significantly different 
from Day 29 (p < 0.005) 
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Figure 8: Leptin Concentrations 
 
Values are mean ± standard error; * Significantly different from Day 1 (p = 0.007);  
✪ Significantly different from Day 29 (p < 0.001) 
 
Figure 9: Ghrelin Concentrations 
 
Values are mean ± standard error; ✪ Significantly different from Day 29 (p = 0.005)  
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CHAPTER 5 
DISCUSSION 
Alternate-day fasting has become a popular dieting method because it promised weight 
loss along with the ability to eat unrestricted during the 24-hour feeding days, despite very low 
caloric intakes sustained on fasting days. The main concept of the the diet claims that individuals 
cannot consume over double their daily need on feeding days, which leads to overall calorie 
deficiencies and weight loss over time [1, 2]. Because rodents would not be influenced by 
psychological appetite triggers, we expected food consumption on feeding days to increase 
enough to offset the caloric deficits on restricted feeding days. While food consumption did 
increase on feeding days, it was not enough to compensate for the caloric deficit incurred on 
fasting days. Food intake in ADF rats only increased by 20% (or 5 g) on feeding days when 
compared to the controls. Consequently, weight gain was stunted in the ADF group. It’s possible 
that the rodents were not able to tolerate more food in the 24-hour period, limiting food intake on 
feeding days. Previous research has shown that when treating for malnourishment, food must be 
re-introduced slowly to avoid complications caused by rapid imbalances of fluid and electrolytes, 
known as refeeding syndrome [43]. Research on refeeding syndrome shows that there is a 
limited amount of food that the body can process after a period of deprivation without adverse 
effects. Though refeeding syndrome is generally seen after prolonged starvation or malnutrition, 
this condition may provide insight into why food intake was lower than expected on fed days.  
Plasma leptin and ghrelin concentrations were measured to determine if the increase in 
food intake could be linked to physiological changes. In both human and rodent studies, 
continuously infused exogenous ghrelin led to increased food intake, with the greatest effect seen 
during central administration [22, 41, 44-46]. However, the role of endogenous ghrelin is still 
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controversial. Some studies have shown that in ghrelin knockout mice, food intake and appetite 
were similar to wild-type counterparts [40, 47].  However, other studies have shown the 
importance of endogenous ghrelin at meal initiation [46, 48, 49]. With of this in mind, we 
hypothesized plasma ghrelin concentrations would not change, since we did not expect total 
intake to be different between groups. Although there was a hyperphagic response on feeding 
days in the ADF group, there were no significant differences in ghrelin between the ADF and 
control group after 30 days.  The possibility of increased ghrelin sensitivity in the ADF rats 
cannot be ruled out.  Increased ghrelin sensitivity may contribute to the increase in food intake 
after fasting days, and would also account for  the higher percent body fat in the ADF group 
since ghrelin has been shown to increase adiposity in rodents [49, 50]. Recent evidence has 
shown that ghrelin promotes fat storage in white adipose tissue and decreases fat utilization in 
skeletal muscles, while increasing carbohydrate utilization [46, 47, 49]. Similar to other rodent 
studies with ADF treatments [15-17, 51], fasting blood glucose concentration decreased in the 
ADF group after 30 days and was significantly lower than the control group. This suggests a 
metabolic shift in fuel usage in the ADF group. Under normal conditions, the reciprocal 
relationship between fat and carbohydrate utilization is necessary to maintain the energy needs of 
various tissues without having to constantly eat. However, alterations in food availability can 
disrupt energy partitioning, leading to excess storage or expenditure [52]. How animals use 
energy can generally be partitioned into two main components: maintenance/repair and 
production/growth. Since food was removed regularly in the ADF group, a shift in substrate 
utilization may have been necessary to store available energy during feeding days for metabolic 
maintenance and repair on fasting days. Evidence for this can be seen with reduced rate of 
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growth and decreased bone mineral density in the ADF group, plus the increased total body and 
trunk fat relative to the control group. 
The expectation of the alternate day fasting diet is that fat mass would decrease, because 
the long fasting intervals would trigger an increase in lipolysis and fat utilization for fuel, as has 
been shown in previous studies [2, 9, 11]. However, we observed the exact opposite. Even 
though weight gain was less in the ADF group compared with the control group, percent total 
body fat was significantly higher with the feeding intervention (Table 3). Trunk fat percentage 
was greater in the ADF group compared with the control group. However, epididymal fat pad 
weight was greater in the control animals, indicating an altered pattern in fat distribution in 
response to ADF. These results are in keeping with the finding of a redistribution of visceral fat 
to subcutaneous fat in mice with calorie restriction and ADF [10]. One explanation for this 
response is that the restriction in food intake was sufficient enough to trigger the starvation 
response leading to increased fat storage. Fat is the body’s long-term storage form of energy, and 
it is thought that this is a mechanism inherited from the hunter-gatherer lifestyle of our ancestors. 
As stated above, the ability to switch between fat and carbohydrate use allows for some 
flexibility in diet and meal timing. When food was not always readily available, extra energy was 
converted into fat during times of food abundance to compensate for intermittent food shortages 
[53]; the “thrifty gene hypothesis.” Though this theory is still strongly debated, our results 
support this concept. It is possible that fasting on alternating days could have stimulated the 
genes that promote fat storage in the ADF group. In contrast, the control group had food that was 
constantly available favoring energy use for growth, as indicated by their higher body weight, 
bone mineral density, and lean body mass percentage.  
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Unlike ghrelin, high levels of leptin stimulate energy expenditure and decrease food 
intake [20, 37, 54]. In rodents, exogenous leptin administration induces weight loss and 
decreased fat mass by activating lipid oxidation and apoptosis in adipocytes [55]. Leptin, which 
is primarily secreted from adipose tissue, increases after feeding in response to high levels of 
insulin and certain amino acids and decreases in response to fasting. Unfortunately, peripheral 
administration of leptin did not result in weight loss for most obese individuals [36, 38, 55]. 
Additionally, elevated leptin levels are found in many obese individuals due to higher amounts 
of body fat and overexpression of leptin from adipose tissue [36]. The inability of these high 
leptin concentrations to decrease food intake and induce weight loss in these individuals 
indicates a defect in leptin receptors and/or post-receptor signaling [55, 56]. The prevailing belief 
is that the physiological role of leptin is to signal the brain during states of negative energy 
balance and decreased energy stores. Lower levels of leptin appear to greatly stimulate the 
mechanisms for fat storage when percent body fat is low. When percent body fat is high, there 
appears to be a mechanistic defect in leptin response and signaling, thus no changes in body fat 
are observed [53]. 
During starvation, leptin levels decrease rapidly to signal the brain for adaptive metabolic 
changes [55, 57]. Because of this, we expected leptin levels to be lower in the ADF group, 
especially on fasting days, with respect to the controls. Our results showed no differences in 
plasma leptin concentrations between diet regimens. Leptin levels in the ADF group were high 
after feeding and low after food restriction. This is consistent with a normal diurnal variation 
leptin. However, the finding of a similar pattern of secretion in the freely eating control group is 
suggestive of a circadian rhythm in leptin secretion, rather than a normal feeding-induced diurnal 
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pattern [20, 58, 59]. This novel finding has not been reported in any other studies to our 
knowledge, as measurements of leptin on consecutive days with ADF have not been reported. 
Our findings indicate that alternate day fasting could be a viable method for weight loss 
as food intake does not appear to increase significantly on feeding days, but conversely may 
result in increases in body fat. These effects may be related to an increased sensitivity to 
circulating ghrelin but are unrelated to changes in leptin. Alternate day fasting appears to have 
triggered an adaptive response which led to a shift in the use of energy from growth/production 
to body maintenance and repair. This response is in keeping with alterations in substrate 
utilization, evidenced by an increased percent body fat with ADF. In addition, the blood glucose 
in ADF animals on a restricted feeding day at the end of the study was significantly decreased 
compared with control animals, indicating a greater utilization of carbohydrates for energy. With 
the continuous search for new and effective weight loss strategies, more research is necessary to 
fully understand the complex metabolic responses to dieting and intermittent fasting. The 
physiological factors that influence food intake and body composition is just one element of 
energy homeostasis. However, the ability to manipulate these factors could lead to the 
development of treatment options for both obesity and anorexia/cachexia. 
 In the present study, male Wistar rats were used, however it not clear if female rats 
would response similarly. Female rats have been shown to preserve lean mass to a greater degree 
than male counterparts during food restriction protocols [60]. As exercise is known to spare lean 
body mass, future research on the effects on body composition and hormone levels with the 
inclusion of an exercise regimen with ADF is warranted. Additionally unlike males, female 
Wistar rats have been shown to increase food intake in response to exercise [60]. Though our rats 
were developmentally considered adults at 10 weeks of age, the control group demonstrated that 
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they were still growing, thus older rodents may generate differing results. Older, weight-stable 
rodents may have different metabolic and hormonal responses to the ADF regimen. The stability 
of the effects of body composition could be determined by switching the ADF group back to an 
ad libitum regimen. Finally, substituting a high-fat chow diet (similar composition to Western 
diets) for the standard chow that was used in the present study may provide more insight into the 
metabolic changes that can occur in human on an ADF regimen.  
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APPENDIX II: 
RAW DATA – BODY WEIGHT 
Subject Pre Week 1 Week 2 Week 3 Week 4 
1 169 227 273 318 343 
2 179 232 260 343 378 
3 173 222 257 288 312 
4 183 244 294 337 373 
5 181 236 291 326 362 
6 177 233 293 335 372 
7 174 225 278 321 346 
Mean 176.57 231.29 278.00 324.00 355.14 
SD 4.89 7.43 15.49 18.24 23.33 
SE 1.85 2.81 5.86 6.89 8.82 
8 187 200 258 265 319 
9 171 188 236 238 288 
10 169 175 220 223 259 
11 166 188 239 237 283 
12 181 187 239 245 305 
13 167 183 236 246 293 
14 174 179 227 233 285 
Mean 173.57 185.71 236.43 241.00 290.29 
SD 7.79 7.99 11.82 13.10 18.77 
SE 2.94 3.02 4.47 4.95 7.09 
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RAW DATA – FOOD INTAKE 
 
Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day 10 
1 9.6 18 20.3 19.2 21.5 19.8 17.1 23.3 22.6 
2 13.1 17.1 18 21.5 19.5 22.1 19.2 23 22 
3 16.2 17.9 15.2 19.7 19.2 18.9 19.2 17.2 18.6 
4 19 18.8 20.1 21.2 19.4 23.9 24.6 20.6 24.1 
5 18.7 16.7 20.9 21.4 20.3 20.6 23.3 22.6 23.4 
6 16.5 18.1 18.2 19.4 18.3 21 19.6 22.8 21.1 
7 13.5 17.3 22.3 21.8 20 20.4 39.3 20.2 24.1 
8 4 22.9 4.1 27.2 4 25.7 4 27.7 4.3 
9 4.1 20.2 4.3 22.1 4 23.7 4.1 26.2 4 
10 4.3 20.5 4.3 25.2 4.2 24.3 4.1 28.6 4.3 
11 3.9 21.6 4 27 4.1 27.6 4.1 27.6 3.9 
12 4.1 24.3 4 28.8 4 26.8 4.1 30.4 4.1 
13 4 20.3 4.2 24 4.3 23.6 4.2 24.6 4.2 
14 4.1 19.4 4 21.3 4 22.2 3.9 23.6 3.9 
 
 
Day 
11 
Day 
12 
Day 
13 
Day 
14 
Day 
15 
Day 
16 
Day 
17 
Day 
18 
Day 
19 
Day 
20 
1 18.1 21 23.9 22.8 22.5 23.8 19.3 23.6 22.4 25.5 
2 22.2 22.4 24.6 25.2 22.3 23.6 25.4 25 24.8 26 
3 18.6 21.2 16.8 16.7 18.2 22.2 19.7 19.6 19.9 21.2 
4 25.3 21.7 26.3 23.9 22.1 25.7 25.8 23 28.3 27.8 
5 30.1 22.5 22.1 22.9 24.4 24.7 23.2 22.6 22.6 27.3 
6 21.2 22.6 25 22.8 25.8 25.1 26.7 21 23.1 25.7 
7 21.9 20 23.5 21.1 23.7 24.1 22.6 22.2 24.2 23.7 
8 27.5 5.1 27.9 5.3 28.6 5.4 32 6.1 34.7 6.1 
9 24 5.2 26.6 5.3 27.7 5.3 31.5 6.2 32.3 5.9 
10 25.5 5 22.5 5.3 28 5.6 29.3 6.1 27.6 6.1 
11 29.7 5.2 29.7 5.2 29.4 5.9 31.3 5.9 34 6 
12 29.7 5 30 5.2 29.7 5.9 31.3 6.1 32.1 5.9 
13 25.5 5 25.2 5.5 26.7 5.3 27.7 6.2 28.7 6 
14 23.8 4.9 27.1 5.4 27.4 5.6 29.9 6.1 29.6 5.9 
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Day 
21 
Day 
22 
Day 
23 
Day 
24 
Day 
25 
Day 
26 
Day 
27 
Day 
28 
Day 
29 
Day 
30 
1 24.3 26.8 25.9 21.8 25.2 22.4 26.4 28.7 21.7 18 
2 25.7 26.9 22.1 24.7 25.4 25.4 26.7 26.9 24.4 15.5 
3 19.5 18 21 19.9 20.7 19.2 19.9 23.3 16.4 19.2 
4 28.6 23.4 31.4 23.3 28.8 28 27.3 31.2 17.9 18 
5 24.2 24.2 27 26.2 28.8 23.1 26.4 28 19.1 17.6 
6 27.7 25.8 30.8 26.6 22.2 24.1 25.9 26.5 25.3 21.9 
7 25.3 26.4 23.9 22.7 25.6 24.6 21.8 27.3 21.5 19.9 
8 33.5 6.1 33.9 5.9 29.5 6.2 33 6.2 32.1 5.9 
9 30.6 6.1 33.2 6 29.3 6.2 28.4 6.3 30.4 6.2 
10 27.2 5.9 28.6 5.8 26.3 6.2 28.4 5.9 26.8 6.2 
11 31.7 6.1 32.7 5.9 29.2 6 28.2 6 30 6.2 
12 33.8 6.2 36.9 6.3 34.2 6.1 31.8 6 32.3 6 
13 29.6 6.2 32.6 6.1 28.5 6.1 29.7 6 30.8 6.1 
14 28.1 6 30.5 6 29.6 6 28.9 6.1 29.6 6.3 
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RAW DATA – BLOOD GLUCOSE 
Subject Day 2 Day 30 
1 95 88 
2 78 107 
3 87 81 
4 92 88 
5 100 82 
6 88 84 
7 85 82 
Mean 89 87 
SD 7.16 9.09 
SE 2.71 3.44 
8 86 50 
9 86 58 
10 90 79 
11 77 70 
12 91 59 
13 89 52 
14 89 54 
Mean 87 60 
SD 4.74 10.53 
SE 1.79 3.98 
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RAW DATA – BODY FAT 
Subject DEXA Body Fat % Trunk % fat Fat Pad Wt (g) 
1 14.9 13.7 3.68 
2 13.2 11.3 2.99 
3 14 11.8 2.98 
4 15.3 15.6 3.89 
5 19.6 18.6 3.75 
6 16.7 15.3 3.88 
7 15.4 13.3 3.83 
Mean 15.6 14.23 3.57 
SD 2.088 2.508 0.407 
SE 0.79 0.95 0.15 
8 15.7 13.3 2.77 
9 18.5 17.4 2.47 
10 24.3 21.6 2.92 
11 24.8 23.3 3.28 
12 17.7 15.5 2.5 
13 19.6 17.7 2.85 
14 18.6 17 2.51 
Mean 19.9 17.97 2.76 
SD 3.406 3.436 0.294 
SE 1.29 1.30 0.11 
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RAW DATA – BONE MINERAL DENSITY 
Subject BMD (g/cm2) 
1 0.168 
2 0.157 
3 0.137 
4 0.166 
5 0.14 
6 0.153 
7 0.134 
Mean 0.151 
SD 0.014 
SE 0.005 
8 0.138 
9 0.135 
10 0.135 
11 0.134 
12 0.139 
13 0.133 
14 0.124 
Mean 0.134 
SD 0.005 
SE 0.002 
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RAW DATA – LEPTIN 
Subject Day 1 Day 2 Day 3 Day 4 
 
Average 
Count 
ng/ml 
Average 
Count 
ng/ml 
Average 
Count 
ng/ml 
Average 
Count 
ng/ml 
1 1160 7.17 1211 6.31 620.75 27.81 1137 7.60 
2 720 21.67 1292.8 5.13 713.35 22.04 1208 6.35 
3 1292 5.14 1115.5 8.02 692.2 23.24 1083 8.70 
4 602.4 29.12 1139 7.56 866.7 14.99 1146.5 7.42 
5 1276.2 5.35 1149 7.37 736 20.82 1057 9.29 
6 658.4 25.30 1079 8.79 715.5 21.92 1055.5 9.32 
7 795.9 17.91 1047.5 9.51 950 12.15 1098 8.38 
Mean 
 
15.95 
 
7.53 
 
20.42 
 
8.15 
SD 
 
10.03 
 
1.47 
 
5.25 
 
1.09 
8 992 10.94 1147 7.41 972.5 11.49 995.1 10.85 
9 1027.2 10.01 1293 5.13 828 16.52 1125.25 7.82 
10 880.5 14.48 1214 6.26 610 28.57 1167 7.04 
11 597 29.52 1176.5 6.88 617.9 28.01 1026 10.04 
12 784.7 18.42 1220 6.17 742.25 20.49 1245 5.79 
13 827.4 16.54 1095.5 8.43 733.75 20.93 1165.6 7.07 
14 721 21.62 1161 7.15 633 26.97 963 11.76 
Mean 
 
17.36 
 
6.78 
 
21.85 
 
8.63 
SD 
 
6.73 
 
1.05 
 
6.43 
 
2.25 
 
 
  
y = -397.8ln(x) + 1943.6
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RAW DATA – GHRELIN 
Subject Day 1 Day 2 Day 3 Day 4 
 
Average 
Count pg/ml 
Average 
Count pg/ml 
Average 
Count pg/ml 
Average 
Count pg/ml 
1 799 1019 992 746 1031 700 632 1336 
2 800 1017 559 1504 806 1008 682 1233 
3 748 1107 706 1186 828 973 786 1041 
4 1233 505 731 1139 1027 705 791 1033 
5 793 1029 972 770 1072 655 780 1051 
6 734 1132 772 1065 632 1335 814 995 
7 274 2385 401 1941 762 1082 489 1683 
Mean  1170.70  1193.02  922.70  1196.07 
SD  576.06  418.96  249.60  248.38 
8 811 1000 741 1119 903 861 407 1923 
9 933 820 714 1169 1141 586 467 1744 
10 681 1234 505 1640 663 1270 607 1392 
11 573 1469 532 1570 985 754 515 1615 
12 907 855 446 1804 1093 633 798 1022 
13 796 1025 830 970 978 763 641 1316 
14 699 1199 895 872 742 1117 641 1316 
Mean  1085.91  1306.53  854.81  1475.34 
SD  229.60  361.47  251.91  304.48 
 
 
 
  
y = -617.9ln(x) + 5079
R² = 0.96724
0
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APPENDIX III 
STATISTICAL ANALYSIS 
Body Weight – ANOVA 
 
Type III Sum of 
Squares df Mean Square F Sig. 
Weight Huynh-Feldt 192206.057 2.303 83448.275 638.084 .000 
Weight * Diet Huynh-Feldt 12532.057 2.303 5440.924 41.604 .000 
Error(Weight) Huynh-Feldt 3614.686 27.640 130.779   
 
Body Weight – Simple Main Effects 
 
 
Levene's Test  t-test for Equality of Means 
F Sig. t df 
Sig. (2-
tailed) 
Mean 
Difference 
WtPre Equal variances assumed 1.393 .261 .863 12 .405 3.000 
WtWeek1 Equal variances assumed .001 .974 11.046 12 .000 45.571 
WtWeek2 Equal variances assumed 1.342 .269 5.645 12 .000 41.571 
WtWeek3 Equal variances assumed .396 .541 9.778 12 .000 83.000 
WtWeek4 Equal variances assumed .641 .439 5.731 12 .000 64.857 
 
Diet Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Control Weight Huynh-Feldt 142884.000 2.272 62899.344 320.511 .000 
Error(Weight) Huynh-Feldt 2674.800 13.630 196.247   
ADF Weight Huynh-Feldt 61854.114 2.410 25661.751 394.862 .000 
Error(Weight) Huynh-Feldt 939.886 14.462 64.989   
 
Average Daily Food Intake – ANOVA 
 
Type III Sum of 
Squares df 
Mean 
Square F Sig. 
Total Intake Sphericity Assumed 159.335 2 79.667 127.865 .000 
Total Intake * Diet Sphericity Assumed 2.650 2 1.325 2.127 .141 
Error(Total Intake) Sphericity Assumed 14.953 24 .623   
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Average Daily Food Intake – Pairwise Comparison 
(I) Total Intake (J) Total Intake 
Mean Difference 
(I-J) Std. Error Sig.b 
1 2 -3.511 .315 .000 
3 -4.553 .364 .000 
2 3 -1.041 .188 .000 
 
Average Fed Day Food Intake – ANOVA  
 
Type III Sum 
of Squares df Mean Square F Sig. 
Fed Intake Sphericity Assumed 185.710 2 92.855 87.890 .000 
Fed Intake * Diet Sphericity Assumed 7.361 2 3.681 3.484 .047 
Error(Fed Intake) Sphericity Assumed 25.356 24 1.056   
 
Average Fed Day Food Intake – Simple Main Effects 
 
Levene's Test t-test for Equality of Means 
F Sig. t df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
FedDay10 Equal variances assumed 1.135 .308 -4.745 12 .000 -4.51429 .95146 
FedDay20 Equal variances assumed .104 .752 -5.682 12 .000 -5.59429 .98452 
FedDay30 Equal variances assumed .062 .807 -6.019 12 .000 -6.56429 1.09064 
 
Diet Source 
Type III Sum of 
Squares df 
Mean 
Square F Sig. 
Control Fed Intake Sphericity 
Assumed 
60.444 2 30.222 31.700 .000 
Error(Fed Intake) Sphericity 
Assumed 
11.440 12 .953   
ADF Fed Intake Sphericity 
Assumed 
132.627 2 66.314 57.186 .000 
Error(Fed Intake) Sphericity 
Assumed 
13.915 12 1.160   
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Body Fat – Independent t-test 
 
Levene's Test  t-test for Equality of Means 
F Sig. t df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
Body Fat Equal variances assumed 1.952 .188 -2.848 12 .015 -4.30000 1.50979 
 
Percent Trunk Fat – Independent t-test 
  Control ADF 
Mean 14.22857143 17.97142857 
Variance 6.292380952 11.80571429 
Observations 7 7 
Pooled Variance 9.049047619 
 Hypothesized Mean Difference 0 
 df 12 
 t Stat -2.327747327 
 P(T<=t) two-tail 0.038226329 
 t Critical two-tail 2.17881283   
 
Fat Pad Weight – Indpenedent t-test 
  Control ADF 
Mean 3.571428571 2.757142857 
Variance 0.165847619 0.086390476 
Observations 7 7 
Pooled Variance 0.126119048 
 Hypothesized Mean Difference 0 
 df 12 
 t Stat 4.289636545 
 P(T<=t) two-tail 0.001050957 
 t Critical two-tail 2.17881283   
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Bone Mineral Density – Independent t-test 
  Control ADF 
Mean 0.150714286 0.134 
Variance 0.000193238 0.000024 
Observations 7 7 
Pooled Variance 0.000108619 
 Hypothesized Mean Difference 0 
 df 12 
 t Stat 3.000328785 
 P(T<=t) two-tail 0.011059936 
 t Critical two-tail 2.17881283   
 
Blood Glucose – t-tests 
 
Control (Post) ADF (Post) 
Mean 87.42857143 60.28571429 
Variance 82.61904762 110.9047619 
Observations 7 7 
Pooled Variance 96.76190476 
 Hypothesized Mean Difference 0 
 df 12 
 t Stat 5.162230337 
 P(T<=t) two-tail 0.000236163 
 t Critical two-tail 2.17881283   
 
 
  ADF (Pre) ADF (Post) 
Mean 86.85714286 60.28571429 
Variance 22.47619048 110.9047619 
Observations 7 7 
Pearson Correlation -0.209352803 
 Hypothesized Mean Difference 0 
 df 6 
 t Stat 5.659799761 
 P(T<=t) two-tail 0.001307211 
 t Critical two-tail 2.446911851   
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Leptin – ANOVA 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Leptin Huynh-Feldt 1885.093 2.230 845.228 22.713 .000 
Leptin * Diet Huynh-Feldt 11.134 2.230 4.992 .134 .895 
Error(Leptin) Huynh-Feldt 995.945 26.763 37.213   
 
Leptin – Pairwise Comparison 
(I) Leptin (J) Leptin 
Mean Difference 
(I-J) Std. Error Sig.b 
1 2 9.505 2.256 .007 
3 -4.483 2.730 .759 
4 8.269 2.322 .024 
2 3 -13.988 1.698 .000 
4 -1.236 .457 .115   
3 4 12.751 1.640 .000 
 
Ghrelin – ANOVA 
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Ghrelin Sphericity Assumed 1584223.768 3 528074.589 6.448 .001 
Ghrelin * Diet Sphericity Assumed 308700.196 3 102900.065 1.256 .304 
Error(Ghrelin) Sphericity Assumed 2948509.286 36 81903.036   
 
Ghrelin – Pairwise Comparison 
(I) Ghrelin (J) Ghrelin Mean Difference (I-J) Std. Error Sig.b 
1 2 -121.357 108.204 1.000 
3 239.571 107.610 .275 
4 -207.429 102.193 .391 
2 3 360.929 110.485 .040 
4 -86.071 118.845 1.000 
3 4 -447.000 100.700 .005 
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